Annie van Broeckhoven
Amministratore Delegato presso CreaBioSupport BV
Profilo
Annie van Broeckhoven is currently the Managing Director at CreaBioSupport BVBA and a Professor at the University of Antwerp.
She previously worked as the Director-Protein Manufacturing at Anethon NV and as the Vice President-Biologicals at Fujirebio Europe NV.
Dr. van Broeckhoven received her undergraduate degree and doctorate from the University of Antwerp in 1981.
Posizioni attive di Annie van Broeckhoven
| Società | Posizione | Inizio |
|---|---|---|
| University of Antwerp | Corporate Officer/Principal | - |
CreaBioSupport BV
 CreaBioSupport BV Miscellaneous Commercial ServicesCommercial Services CreaBioSupport BVBA provides business consulting services. It develops process and analytical methods for biologicals and production including GMP manufacturing, quality control, and regulatory. The company is headquartered in Antwerp, Belgium. | Amministratore Delegato | - |
Precedenti posizioni note di Annie van Broeckhoven
| Società | Posizione | Fine |
|---|---|---|
Anethon NV
 Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Corporate Officer/Principal | 07/08/2013 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - |
Formazione di Annie van Broeckhoven
| University of Antwerp | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
CreaBioSupport BV
CreaBioSupport BV Miscellaneous Commercial ServicesCommercial Services CreaBioSupport BVBA provides business consulting services. It develops process and analytical methods for biologicals and production including GMP manufacturing, quality control, and regulatory. The company is headquartered in Antwerp, Belgium. | Commercial Services |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Health Technology |
- Borsa valori
- Insiders
- Annie van Broeckhoven